MGRO.F Stock Overview

An agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. More details

MGRO.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the US market

Earnings are forecast to decline by an average of 69.1% per year for the next 3 years

Shareholders have been diluted in the past year

Does not have meaningful revenue (CA$5M)

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

MustGrow Biologics Corp. Competitors

Muliang Viagoo Technology

OTCPK:MULG

US$49.1m

American Vanguard

NYSE:AVD

US$125.2m

Enlightify

NYSE:ENFY

US$17.8m

Bioceres Crop Solutions

NasdaqGS:BIOX

US$397.2m

Price History & Performance

Summary of share price highs, lows and changes for MustGrow Biologics
Historical stock prices
Current Share Price	CA$0.83
52 Week High	CA$1.73
52 Week Low	CA$0.41
Beta	1.32
1 Month Change	-32.91%
3 Month Change	0.18%
1 Year Change	-7.57%
3 Year Change	-71.21%
5 Year Change	70.93%
Change since IPO	69.78%

Recent updates

Shareholder Returns

	MGRO.F	US Chemicals	US Market
7D	-8.3%	-3.4%	-2.2%
1Y	-7.6%	-3.6%	23.9%

Return vs Industry: MGRO.F underperformed the US Chemicals industry which returned -3.6% over the past year.

Return vs Market: MGRO.F underperformed the US Market which returned 23.9% over the past year.

Price Volatility

Is MGRO.F's price volatile compared to industry and market?
MGRO.F volatility
MGRO.F Average Weekly Movement	17.3%
Chemicals Industry Average Movement	5.5%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: MGRO.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: MGRO.F's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

Founded	Employees	CEO	Website
2014	n/a	Corey Giasson	mustgrow.ca

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. The company also offers TerraMG, a mustard-derived soil biopesticide technology.

MustGrow Biologics Corp. Fundamentals Summary

How do MustGrow Biologics's earnings and revenue compare to its market cap?
MGRO.F fundamental statistics
Market cap	US$43.54m
Earnings (TTM)	-US$170.74k
Revenue (TTM)	US$3.48m

12.5x

P/S Ratio

-255.0x

P/E Ratio

Is MGRO.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MGRO.F income statement (TTM)
Revenue	CA$4.99m
Cost of Revenue	CA$255.69k
Gross Profit	CA$4.74m
Other Expenses	CA$4.98m
Earnings	-CA$245.03k

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0047
Gross Margin	94.88%
Net Profit Margin	-4.91%
Debt/Equity Ratio	15.4%

How did MGRO.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 01:19
End of Day Share Price	2024/12/24 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MustGrow Biologics Corp. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Joseph Gomes	NOBLE Capital Markets, Inc.